Neurogene Inc. ( NGNE) - Stock Earnings
NGNE Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 10, 2026, midnight | — / — | — | — / — | — |
NGNE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -21.0 million USD | — USD |
| 2025Q4 | -24.7 million USD | — USD |
| 2026Q1 | -30.9 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
NGNE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -36.3 million USD | — USD |
| 2024 | -75.1 million USD | 925000 USD |
| 2025 | -90.4 million USD | — USD |
| 2026 Est. | — | — |
NGNE
Price: $34.90
52 week price:
Earnings Per Share: -4.55 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 558.4 million